WHO ICTRP trial
A multiple centre parallel group study comparing test drug Brinzolamide 1%…
CTRI/2015/01/005379 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2015/01/005379 |
|---|---|
| Public title | A multiple centre parallel group study comparing test drug Brinzolamide 1% ophthalmic suspension to reference product of Brinzolamide (Azopt®) 1% ophthalmic suspension in the treatment of chronic open angle glaucoma or ocular hypertension in both eyes |
| Scientific title | A multicentre, double blind, active controlled, parallel group, two arm, bioequivalence study with clinical endpoint comparing Brinzolamide 1% ophthalmic suspension (manufactured by Indoco Remedies Ltd. for Watson Pharma Pvt Ltd.), to Brinzolamide (Azopt®) 1% ophthalmic suspension of Alcon… |
| Primary sponsor | Watson Pharma Pvt Ltd India |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | BA/BE |
| Countries | India |
| Conditions | Health Condition 1: null- Primary open angle glaucoma or ocular hypertension |
| Interventions | Intervention1: Brinzolamide Ophthalmic suspension 1%, Manufactured by: Indoco Remedies, Ltd for Watson Pharma Pvt. Ltd: Each study subject will use 1 drop of test drug (Brinzolamide Ophthalmic Suspension 1%) in both the eyes 3 times daily… |
| Registration date | Sep 1, 2015 |
| Target size | 950 |
| Secondary IDs | WAT/BNZL/2014, Version 3.0, 5 October 2015 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: